T/Null Cell Systemic Type
1 clinical trials · Condition
◉ Watch T/Null Cell Systemic Type
| Record | Firm | Date |
|---|---|---|
| Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas (NCT00704691) | University of Alabama at Birmingham | 2008-06-01 |
Track T/Null Cell Systemic Type automatically
Every clearance here is in the API, with alerts when new ones post.